Nutraceutical composition comprising inulin for treating and preventing ocular disorders or intestinal microbiota imbalance
US-2024165149-A1 · May 23, 2024 · US
Compositions containing riboflavin and sesamin-class compounds
US9895375B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9895375-B2 |
| Application number | US-201414551188-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 24, 2014 |
| Priority date | Mar 15, 2006 |
| Publication date | Feb 20, 2018 |
| Grant date | Feb 20, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to a composition containing riboflavin and a sesamin-class compound(s). This composition may incorporate a sesamin-class compound(s) in such an amount that the proportion (weight ratio) of its total quantity to the total quantity of riboflavin taken as unity is no more than 4.5, and it has the advantage that the analgesic and anti-fatigue actions of riboflavin are synergistically improved by ingestion of riboflavin in combination with a sesamin-class compound(s). The composition of the present invention provides compositions, in particular, pharmaceuticals as well as foods and beverages that are safe to humans, animals, etc., and can therefore be ingested for a continued period, and which have far superior effects to those of conventional foods having an analgesic or anti-fatigue action.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method of reducing pain in a subject, comprising: administering a composition containing an effective amount of riboflavin and a sesamin-class compound(s) selected from the group consisting of sesamin, episesamin, sesaminol, episesaminol, and sesamolin to a subject in need thereof, wherein the composition consists essentially of riboflavin and the sesamin class compound(s), and wherein a proportion (weight ratio) of the total quantity of the sesamin-class compound(s) to the total quantity of riboflavin taken as unity in the composition is no more than 4.5. 2. The method according to claim 1 , wherein the sesamin-class compound(s) contained in the composition is selected from the group consisting of sesamin and episesamin. 3. A method of reducing fatigue in a subject comprising: administering a composition containing an effective amount of riboflavin and a sesamin-class compound(s) selected from the group consisting of sesamin, episesamin, sesaminol, episesaminol, and sesamolin to a subject in need thereof, wherein the composition consists essentially of riboflavin and the sesamin class compound(s), and wherein a proportion (weight ratio) of the total quantity of the sesamin-class compound(s) to the total quantity of riboflavin taken as unity in the composition is no more than 4.5. 4. The method according to claim 3 , wherein the sesamin-class compound(s) contained in the composition is selected from the group consisting of sesamin and episesamin.
Assignees
Inventors
Classifications
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Drugs for disorders of the nervous system · CPC title
Centrally acting analgesics, e.g. opioids · CPC title
Nutrients, e.g. vitamins, minerals · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9895375B2 cover?
- The present invention relates to a composition containing riboflavin and a sesamin-class compound(s). This composition may incorporate a sesamin-class compound(s) in such an amount that the proportion (weight ratio) of its total quantity to the total quantity of riboflavin taken as unity is no more than 4.5, and it has the advantage that the analgesic and anti-fatigue actions of riboflavin are …
- Who is the assignee on this patent?
- Suntory Holdings Ltd
- What technology area does this patent fall under?
- Primary CPC classification A61K31/525. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).